Start Activity

IOS

IOS

IBD Virtual Clinic

gastro

Overview of Virtual Clinic Activity

The IBD Virtual Clinic is a unique opportunity for clinicians to witness optimal treatment approaches as practiced in the clinic setting, and learn through interactive case-based experiences.

Release Date: 3/3/2014
Expiration Date: 3/3/2016

Statement of Need

Inflammatory bowel disease (IBD) represents one of the most frequently encountered conditions in primary care and poses a constant challenge for gastroenterologists to manage. The two primary types of IBD, Crohn's disease (CD) and ulcerative colitis (UC), are chronic, heterogenic, lifelong illnesses with a young age of onset and a great potential for disability. Thus, educating physicians about evidence-based methods for optimizing the treatment of IBD, specifically with pharmacologic therapies, may improve both patient adherence to treatment and patient outcomes.

Target Audience

This activity is intended for gastroenterologists and other physicians who manage patients with IBD.

Learning Objectives

Upon completion of this activity, participants will be able to:
  • Analyze therapeutic IBD options for various patient populations in the context of treatment guidelines and algorithms
  • Apply knowledge of IBD medications (mechanisms of action, dosing regimens, safety profiles, and evidence of effectiveness) in order to tailor therapy to the individual patient
  • Implement evidence-based methods and patient education to help optimize IBD treatment strategies and quality of life

Sponsors

Cosponsored by Indiana University School of Medicine and the Academy for Continued Healthcare Learning

Acknowledgements

Our grateful acknowledgement to AbbVie Inc., Shire, and UCB, Inc. for educational grants in support of this program.

System Requirements

Windows

  • 1.4GHz Intel® Pentium® 4 or faster processor (or equivalent) for Microsoft® Windows® XP or Windows 7; 2GHz Pentium 4 or faster processor (or equivalent) for Windows Vista®
  • Windows XP, Windows Vista, or Windows 7
  • 512MB of RAM (1GB recommended) for Windows XP or Windows 7; 1GB of RAM (2GB recommended) for Windows Vista
  • Microsoft Internet Explorer 7, 8, 9; Mozilla Firefox; Google Chrome
  • Adobe® Flash® Player 8.0 or higher

Mac OS

  • 1.83GHz Intel Core™ Duo or faster processor
  • 512MB of RAM (1GB recommended)
  • Mac OS X, 10.5, 10.6, 10.7.4, 10.8
  • Mozilla Firefox; Apple Safari; Google Chrome
  • Adobe® Flash® Player 8.0 or higher

iPad and Android

iPad

  • App is only compatible on iPad 2 (2nd generation) or higher
  • App is not optimized for MAC or iPhone (any versions)

Android

  • App is optimized to run only on Android Tablets, supporting Android OS 2.3 and higher
  • Minimum processor requirement: 1 GHz
  • Minimum RAM requirement: 512 MB
  • App is designed for 1280 px wide x 800 px high resolution, and will scale up/down proportionately for other tablet resolutions.

lichtenstein_gary

Chair

Gary Lichtenstein, MD

Professor of Medicine
Department of Gastroenterology
University of Pennsylvania School of Medicine

Director
Center for IBD
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania

david_rubin

Faculty

David Rubin, MD

Professor of Medicine
Department of Medicine, Section of Gastroenterology
University of Chicago Medicine
Chicago, Illinois

 

DISCLOSURES

Indiana University School of Medicine requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. Conflict resolution must occur prior to the CME/CE activity. Indiana University School of Medicine also requires participating faculty to disclose when unapproved/unlabeled uses of a product are discussed in a CME/CE activity.

This CME activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. Indiana University School of Medicine requires the speaker to disclose that a product is not labeled for the use under discussion. The provider’s documentation of common practices that make the disclosure requirement known to faculty demonstrates compliance with ACCME guidelines.

The faculty members have provided the following disclosure information.

Faculty Disclosures

Gary Lichtenstein, MD (Chair) Type of financial relationships:
Consulting Agreements: Abbott Laboratories; Alaven Pharmaceuticals; Janssen Biotech, Inc; Elan Pharmaceuticals, Inc; Ferring Pharmaceuticals; Hospira, Inc; Meda Pharmaceuticals; Millennium Pharmaceuticals; Ono Pharmaceuticals; Pfizer Pharmaceuticals; Proctor & Gamble; Prometheus Laboratories, Inc.; Salix Pharmaceuticals; Santarus, Inc; Schering-Plough Corporation; Shire Pharmaceuticals; Takeda Pharmaceutical Co., Ltd; UCB, Inc; Warner Chilcotte; Wyeth Pharmaceuticals
Sources of Funding for Research: Alaven Pharmaceutical; Bristol-Myers Squibb Company; Janssen Biotech, Inc; Ferring Pharmaceuticals; Proctor & Gamble; Prometheus Laboratories, Inc.; Salix Pharmaceuticals; Shire Pharmaceuticals; UCB, Inc; Warner Chilcotte
Discussion of Off-Label, Investigational, or Experimental Drug Use: None

David Rubin, MD (Faculty) Type of financial relationships:
Grant Support: AbbVie Inc; Elan Pharmaceuticals, Inc; Prometheus Laboratories, Inc.; Shire; Warner Chilcotte
Consulting Agreements: AbbVie Inc; Bristol-Myers Squibb Company; Centocor/Janssen; Elan Pharmaceuticals, Inc; Emmi; Given Imaging; Ironwood Pharmaceuticals, Inc; Lifecore Biomedical, LLC; Prometheus Laboratories, Inc.; Santarus, Inc; Takeda-Millennium; Telsar Pharmaceuticals; UCB, Inc; Vertex Pharmaceuticals
Discussion of Off-Label, Investigational, or Experimental Drug Use: None

STAFF AND REVIEWER DISCLOSURES

ACHL and Indiana University School of Medicine staff members, and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Dr. Rubin independently developed the slides and images within the ulcerative colitis case presentation.

 

CME Information

Indiana University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Indiana University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Note

While it offers CME credits, this activity is not intended to provide extensive training or certification in the field.

Disclaimer

The content for this activity was developed independently of the commercial supporters. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publishers or grantors.

This educational activity was planned and produced in accordance with the ACCME Essential Areas and Elements, Updated Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

Method of Participation

This online activity will take approximately 60 minutes to complete. To receive credit, participants are required to complete an evaluation form at the conclusion of the program, and achieve 75% on the post-test. A certificate will be immediately available.
 

FAQs

Q.
May I pause the activity in the middle of a case and return at a later time to complete it?
A.
Users can pause the activity at any time during viewing. If you exit the activity, the program will resume from the beginning upon reentry. Users do not, however, need to complete a pre or post test more than once.
Q.
Who do I contact if I have technical difficulties with this online portal?
A.
Please contact Vanessa Senatore, Associate Program Director, with ACHL.
Email: vsenatore@achlcme.org; Phone: (773) 714-0705 x 189
Q.
Is a mobile option of the activity available?
A.
Yes, this CME activity is available on an iPad and Android tablet.

Patient Resources


Downloadable Resources


RESOURCE
DETAILS
American Gastroenterological Association.
IBD self-management. The AGA guide to Crohn’s disease and ulcerative colitis. Available for purchase at http://www.ibdselfmanagement.com/order.html
Crohn’s and Colitis Foundation of America (CCFA)
CCFA provides an overview of the need for maintenance therapy and the types of maintenance therapies that exist.

CCFA. Maintenance therapy. 2011.

Available at http://www.ccfa.org/resources/maintenance-therapy.html.
Crohn’s and Colitis Foundation of America (CCFA).
Patient brochures. A variety of both English, Spanish, and pediatric patient brochures are offered for use.

Accessible at http://www.ccfa.org/science-and-professionals/programs-materials/patient-brochures/
Crohn’s and Colitis Foundation of America (CCFA)
Find studies and clinical trials.

http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/
Crohn’s and Colitis Foundation of America (CCFA)
Search a listing of CCFA’s resources for either Crohn’s disease or ulcerative colitis.

http://www.ccfa.org/resources/
International Foundation for Functional Gastrointestinal Disorders (IFFGD)
Living with IBS. Includes guidance, personal stories from other patients, and tips on travel and pregnancy when living with IBS.

http://www.aboutibs.org/site/living-with-ibs/
National Institute of Diabetes and Digestive Diseases (NIDDK)
Informational overview and resources for patients on

Crohn’s disease
http://digestive.niddk.nih.gov/ddiseases/pubs/crohns/index.aspx

Ulcerative colitis
http://digestive.niddk.nih.gov/ddiseases/pubs/colitis/index.aspx
Practice Guidelines, Crohn’s disease
Lichtenstein GR, Hanauer SB, Sandborn WJ, The Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn’s disease in adults. Am J Gastroenterol. 2009.

To download the pdf, please access the pdf link located at http://gi.org/guideline/management-of-crohn%E2%80%99s-disease-in-adults/
Practice Guidelines, ulcerative colitis
Kornbluth A, Sachar DB, The Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee.

To download the pdf, please access the pdf link located at http://gi.org/guideline/ulcerative-colitis-in-adults/

Links to external websites are provided only for your convenience. The Academy for Continued Healthcare Learning (ACHL) does not endorse any external websites. The sites are not under the control of ACHL and we are not responsible for their content or privacy policies.



Achl
Copyright © 2014 Academy for Continued Healthcare Learning
Terms and Conditions/Privacy Policy

Contact Us

If you have questions about this program, please contact Vanessa Senatore with ACHL.


Phone: 773-714-0705 x189
Email: vsenatore@achlcme.org

 
close

As a guest user, you may complete this activity without creating a user profile/account. If you would like to save your progress or receive a certificate, you can create an account at any point during the activity, or upon completion. This also allows you to start/stop the activity as desired, and start back up where you left off. If you leave the activity without creating an account/logging in, your responses to the Virtual Clinic questions will not be saved, and you will be asked to start the activity from the beginning upon returning. 

Click on the "Start Activity" button below to begin the activity as a guest, or select "Sign in now" if you would like to create  new account

(*)

Already have a account?